Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir versus zanamivir for influenza resistance emergence
ACTRN12609000906257Phase 4Recruiting
- Sponsor
- Prof Robert Booy
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in influenza comparing Oseltamivir with Zanamivir (2 arms). Primary endpoint: Frequency of isolation of resistant virus in subjects aged 5 years or greater. Started Aug 2009; status: recruiting.
02
Drugs
oseltamivirzanamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ACTRN12609000906257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000906257.